Skip to the page

Data / Drug companies / Actavis Pharma, Inc.

Actavis Pharma, Inc.: 87 products in the FDA NDC directory, labeler code 0228

Actavis Pharma, Inc. (labeler code 0228) lists 87 products in the FDA National Drug Code Directory, covering 20 finished drugs by generic name. By type: 67 prescription drugs, 20 drugs for further processing. Its main marketing category is generic drugs (ANDA). The newest product started marketing on February 14, 2025.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0228
Products in commercial distribution
87
Packages
119
Finished drugs by generic name
20
Prescription products
67
Over the counter products
0
Controlled substance products
Schedule II 12, Schedule III 4, Schedule IV 20
Flagged as original packager
57 of 57 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
13
Earliest marketing start
September 30, 1990
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)6574.7%
Drugs for further processing2023%
Authorized generics (NDA)22.3%

Products by type

TypeProductsShare
Prescription drugs6777%
Drugs for further processing2023%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Capsule, extended release2124.1%
Tablet2023%
Tablet, film coated1213.8%
Tablet, film coated, extended release910.3%
Capsule, delayed release pellets66.9%
Capsule, gelatin coated66.9%
Tablet, extended release55.7%
Tablet, orally disintegrating44.6%
Capsule22.3%
Tablet, delayed release22.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Fluvoxamine maleate0228-2849Capsule, extended releaseDrugs for further processingFebruary 14, 2025
Fluvoxamine maleate0228-2848Capsule, extended releaseDrugs for further processingFebruary 14, 2025
Duloxetine0228-2892Capsule, delayed release pelletsDrugs for further processingFebruary 1, 2024
Duloxetine0228-2891Capsule, delayed release pelletsDrugs for further processingFebruary 1, 2024
Duloxetine0228-2890Capsule, delayed release pelletsDrugs for further processingFebruary 1, 2024
Oxazepam0228-2073Capsule, gelatin coatedDrugs for further processingSeptember 29, 2023
Oxazepam0228-2069Capsule, gelatin coatedDrugs for further processingSeptember 29, 2023
Oxazepam0228-2067Capsule, gelatin coatedDrugs for further processingSeptember 29, 2023
Doxepin0228-3316Tablet, film coatedDrugs for further processingAugust 25, 2023
Doxepin0228-3315Tablet, film coatedDrugs for further processingAugust 25, 2023
Indapamide0228-2597Tablet, film coatedDrugs for further processingMay 16, 2023
Indapamide0228-2571Tablet, film coatedDrugs for further processingMay 16, 2023
Isosorbide mononitrate0228-2631TabletDrugs for further processingFebruary 7, 2023
Isosorbide mononitrate0228-2620TabletDrugs for further processingFebruary 7, 2023
Doxepin0228-3316Tablet, film coatedGeneric drugs (ANDA)January 2, 2020
Doxepin0228-3315Tablet, film coatedGeneric drugs (ANDA)January 2, 2020
Lamotrigine0228-1638Tablet, film coated, extended releaseGeneric drugs (ANDA)June 1, 2016
Lamotrigine0228-1580Tablet, film coated, extended releaseGeneric drugs (ANDA)April 1, 2016
Lamotrigine0228-1453Tablet, film coated, extended releaseGeneric drugs (ANDA)April 1, 2016
Lamotrigine0228-1422Tablet, film coated, extended releaseGeneric drugs (ANDA)April 1, 2016
Alprazolam0228-2039TabletDrugs for further processingJuly 30, 2015
Alprazolam0228-2031TabletDrugs for further processingJuly 30, 2015
Alprazolam0228-2029TabletDrugs for further processingJuly 30, 2015
Alprazolam0228-2027TabletDrugs for further processingJuly 30, 2015
Clonidine Hydrochloride0228-4241Tablet, extended releaseGeneric drugs (ANDA)June 17, 2015

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.